Antibody formulations

Details for Australian Patent Application No. 2008275278 (hide)

Owner GlaxoSmithKline LLC

Inventors Ketkar, Amol Sharad; Lashmar, Ulla Tove; Brisbane, Charlene E.

Agent Davies Collison Cave

Pub. Number AU-B-2008275278

PCT Pub. Number WO2009/009407

Priority 60/948,220 06.07.07 US

Filing date 3 July 2008

Wipo publication date 15 January 2009

Acceptance publication date 14 April 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/009407 Priority application(s): WO2009/009407

14 April 2011 Application Accepted

  Published as AU-B-2008275278

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008275281-Methods of calibrating a fluid analyzer for use in a wellbore

2008275270-Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimeth ylphenyl)-propionyl]-[1-(4-phenyl-1h-imid azol2-yl)-ethyl]-amino}-methyl)-2-methoxybenzoic acid